Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.42 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.42 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30545253 | 0.79 | ALDH1A1 (0.52) | ALDH1A1TSHRHPGDHSD17B10CYP3A4 | |
| SCHEMBL29428696 | 0.79 | ALDH1A1 (0.52) | ALDH1A1TSHRHPGDHSD17B10CYP3A4 | |
| SCHEMBL5403909 | 0.79 | ALDH1A1 (0.52) | ALDH1A1TSHRHPGDHSD17B10CYP3A4 | |
| SCHEMBL26011160 | 0.79 | ALDH1A1 (0.52) | ALDH1A1TSHRHPGDHSD17B10CYP3A4 | |
| SCHEMBL26011162 | 0.79 | ALDH1A1 (0.52) | ALDH1A1TSHRHPGDHSD17B10CYP3A4 | |
| SCHEMBL8561083 | 0.79 | ALDH1A1 (0.48) | ALDH1A1TSHRHPGDHSD17B10CYP3A4 | |
| SCHEMBL24788859 | 0.79 | ALDH1A1 (0.45) | ALDH1A1TSHRHPGDHSD17B10CYP3A4 | |
| SCHEMBL29134975 | 0.79 | ALDH1A1 (0.45) | ALDH1A1TSHRHPGDHSD17B10CYP3A4 | |
| SCHEMBL26198747 | 0.79 | ALDH1A1 (0.45) | ALDH1A1TSHRHPGDHSD17B10CYP3A4 | |
| SCHEMBL28357450 | 0.78 | ALDH1A1 (0.59) | ALDH1A1TSHRHPGDHSD17B10CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106147887-B | Methanol gasoline multiphase corrosion inhibitor and methanol gasoline prepared from same | 福建中源新能源股份有限公司 | 2018-05-04 | — | — | CN | claimed |
| US-10336717-B2 | Inhibitors of beta-secretase | VITAE PHARMACEUTICALS, LLC (US) | 2019-07-02 | — | — | US | disclosed |
| CN-106147887-B | Methanol gasoline multiphase corrosion inhibitor and methanol gasoline prepared from same | 福建中源新能源股份有限公司 | 2018-05-04 | — | — | CN | disclosed |
| CN-106147887-A | Methanol gasoline multiphase corrosion inhibitor and methanol gasoline prepared from same | 福建中源新能源股份有限公司 | 2016-11-23 | — | — | CN | disclosed |
| US-20160272600-A1 | INHIBITORS OF BETA-SECRETASE | VITAE PHARMACEUTICALS, LLC | 2016-09-22 | — | — | US | disclosed |
| EP-2406240-B1 | INHIBITORS OF BETA-SECRETASE | VITAE PHARMACEUTICALS INC (US) | 2015-12-23 | — | — | EP | disclosed |
| US-9212153-B2 | Inhibitors of beta-secretase | VITAE PHARMACEUTICALS, INC. (US) | 2015-12-15 | — | — | US | disclosed |
| EP-2801570-A1 | Inhibitors of beta-secretase | Vitae Pharmaceuticals, Inc. (US) | 2014-11-12 | — | — | EP | disclosed |
| US-20140200223-A1 | INHIBITORS OF BETA-SECRETASE | VITAE PHARMACEUTICALS, INC. | 2014-07-17 | — | — | US | disclosed |
| US-8633212-B2 | Inhibitors of beta-secretase | VITAE PHARMACEUTICALS, INC. (US) | 2014-01-21 | — | — | US | disclosed |
| EP-2406240-A2 | INHIBITORS OF BETA-SECRETASE | Vitae Pharmaceuticals, Inc. (US) | 2012-01-18 | — | — | EP | disclosed |
| US-20110071126-A1 | INHIBITORS OF BETA-SECRETASE | VITAE PHARMACEUTICALS, INC. | 2011-03-24 | — | — | US | disclosed |
| WO-2010105179-A2 | INHIBITORS OF BETA-SECRETASE | VITAE PHARMACEUTICALS, INC. (US) | 2010-09-16 | — | — | WO | disclosed |
| US-5298622-A | Spiroindane opiate analogs | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1994-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140200223-A1 | INHIBITORS OF BETA-SECRETASE | BACE1, BACE2, PSEN1 | ALDH1A1 2962/4885TSHR 4800/4885HPGD 2354/4885 |
| US-10336717-B2 | Inhibitors of beta-secretase | BACE1, BACE2, PSEN1 | ALDH1A1 2962/4885TSHR 4800/4885HPGD 2354/4885 |
| US-20160272600-A1 | INHIBITORS OF BETA-SECRETASE | BACE1, BACE2, PSEN1 | ALDH1A1 2962/4885TSHR 4800/4885HPGD 2354/4885 |
| US-20110071126-A1 | INHIBITORS OF BETA-SECRETASE | BACE1, BACE2, PSEN1 | ALDH1A1 2962/4885TSHR 4800/4885HPGD 2354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.